Page 126 | Certara

Blog

Formatting Annotated Case Report Forms (aCRFs): Document properties, bookmarking and table of contents

Discover essential tips for formatting annotated CRFs, from dual bookmarking to document properties. Read the…

CertaraSeptember 10, 2020

Fact Sheet

Secondary Intelligence

Predicts off-target risks, streamlining secondary pharmacology analysis for safer drug development.

CertaraSeptember 4, 2020

On-Demand Webinar

Exploring Common CDISC ADaM Dataset Conformance Findings

What you need to know when validating your CDISC ADAM datasets During the regulatory review…

CertaraSeptember 3, 2020

Publication

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted

As of July 28, 2020, 1840 clinical trials were registered globally, with 1001 clinical trials…

CertaraAugust 22, 2020

Publication

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…

CertaraAugust 22, 2020

Case Study

Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research

In February 2020, we announced that Certara’s discovery research relationship with Arvinas had expanded to…

CertaraAugust 21, 2020

Fact Sheet

Regulatory Operations

CertaraAugust 13, 2020

Fact Sheet

Scientific and Medical Communications

CertaraAugust 13, 2020

Blog

Formatting Annotated Case Report Forms (aCRFs): Part 1

Discover essential tips for formatting aCRFs with clarity and regulatory compliance in mind. Read the…

CertaraAugust 12, 2020

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

CertaraAugust 7, 2020

Formatting Annotated Case Report Forms (aCRFs): Document properties, bookmarking and table of contents

Secondary Intelligence

Exploring Common CDISC ADaM Dataset Conformance Findings

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research

Regulatory Operations

Scientific and Medical Communications

Formatting Annotated Case Report Forms (aCRFs): Part 1

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

Newsletter sign up

Quick links

Solutions

Contact